Factor VIII levels in plasma and characterization of anti–factor VIII autoantibodies in 3 patients with acquired hemophilia A
Patient . | Plasma level . | Inhibitor neutralization by FVIII domain, % . | Inhibition of IgG binding to FVIII, % . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FVII:C (U/dL) . | FVII:Ag (U/dL) . | Anti-FVII:C (BU/mL) . | 80-kd LCh . | 72-kd LCh . | HCh . | C2 . | A2 . | 80-kd LCh . | 72-kd LCh . | HCh . | C2 . | A2 . | |
1 | 4.1 | 101 | 4.9 | > 95 | > 95 | < 5 | < 5 | < 5 | > 95 | > 95 | < 5 | < 5 | < 5 |
2 | 4.3 | 98 | 3.5 | > 95 | > 95 | < 5 | < 5 | < 5 | > 95 | > 95 | < 5 | < 5 | < 5 |
3 | 3.6 | 87 | 5.3 | > 95 | > 95 | < 5 | < 5 | < 5 | > 95 | > 95 | < 5 | < 5 | < 5 |
Patient . | Plasma level . | Inhibitor neutralization by FVIII domain, % . | Inhibition of IgG binding to FVIII, % . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FVII:C (U/dL) . | FVII:Ag (U/dL) . | Anti-FVII:C (BU/mL) . | 80-kd LCh . | 72-kd LCh . | HCh . | C2 . | A2 . | 80-kd LCh . | 72-kd LCh . | HCh . | C2 . | A2 . | |
1 | 4.1 | 101 | 4.9 | > 95 | > 95 | < 5 | < 5 | < 5 | > 95 | > 95 | < 5 | < 5 | < 5 |
2 | 4.3 | 98 | 3.5 | > 95 | > 95 | < 5 | < 5 | < 5 | > 95 | > 95 | < 5 | < 5 | < 5 |
3 | 3.6 | 87 | 5.3 | > 95 | > 95 | < 5 | < 5 | < 5 | > 95 | > 95 | < 5 | < 5 | < 5 |
FVIII indicates factor VIII; FVIII:C, FVIII activity; FVIII:Ag, FVIII antigen; BU, Bethesda unit; LCh, light chain; HCh, heavy chain.